35 results
8-K
EX-10.1
COGT
Cogent Biosciences Inc
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”). Neither the Company nor any of its … regarding an individual’s medical history, mental or physical condition, or medical treatment or diagnosis by a health care professional; (iv
8-K
EX-1.1
COGT
Cogent Biosciences Inc
8 Jun 23
Entry into a Material Definitive Agreement
4:31pm
been excluded, suspended or debarred from participation in any state or federal health care program, or made subject to any pending
8-K/A
EX-1.1
qjvjds1g3xqy0orll6l
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-1.1
rhsohx1r
15 Jun 22
Entry into a Material Definitive Agreement
5:18pm
8-K
EX-1.1
xtj3 2wlhtmbk
2 Dec 20
Entry into a Material Definitive Agreement
5:08pm
424B5
loduhld
2 Dec 20
Prospectus supplement for primary offering
5:06pm
424B5
ysj3t6wdjgtevswjsups
30 Nov 20
Prospectus supplement for primary offering
5:28pm
DEFM14A
3zmxzn qzw
9 Oct 20
Proxy related to merger
4:44pm